Induced pluripotent cancer cells: progress and application.

Abstract:

:Induced pluripotent stem (iPS) cells are a group of pluripotent stem cells artificially derived from non-pluripotent cells typically by a forced expression of specific transcription factors. Generation of cancer-specific iPS cells, also called induced pluripotent cancer (iPC) cells, provides valuable experimental platform to model oncogenesis and holds great potential in the fields of drug screening. However, iPC cells are harder to achieve than normal iPS cells probably because of the special genetic and epigenetic states of cancer cells. To help overcome this hurdle of iPC research and to prospect this promising field, this review emphasizes the experimental issues of reprogramming cancer into iPC cells, and discusses the potential of iPC cells in cancer research.

authors

Sun C,Liu YK

doi

10.1007/s00432-010-0955-z

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

1-8

issue

1

eissn

0171-5216

issn

1432-1335

journal_volume

137

pub_type

杂志文章,评审
  • Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer.

    abstract:BACKGROUND:Carbonic anhydrase IX (CAIX) is involved in pH homeostasis, growth and survival of tumor cells. Besides the membranous form of CAIX, a soluble form is detectable in serum (s-CAIX). Overexpression of CAIX in tumors offers the opportunity for therapeutic strategies such as CAIX targeting antibodies. The aim of...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-013-1378-4

    authors: Schütze D,Milde-Langosch K,Witzel I,Rody A,Karn T,Schmidt M,Choschzick M,Jänicke F,Müller V

    更新日期:2013-05-01 00:00:00

  • Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.

    abstract:PURPOSES:Genetic variations among prostate cancer patients who underwent radical prostatectomies were evaluated to predict biochemical recurrence, and used to develop a clinical-genetic model that combines data on clinicopathological factors of prostate cancer and individual genetic variations. MATERIALS AND METHODS:W...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-015-1947-9

    authors: Oh JJ,Park S,Lee SE,Hong SK,Lee S,Lee HM,Lee JK,Ho JN,Yoon S,Byun SS

    更新日期:2015-08-01 00:00:00

  • Determination of growth kinetics in a renal sarcoma of the rat by double labeling with 14C- and 3H-thymidine.

    abstract::An in vitro double-labeling technique for determination of kinetic growth parameters was tested; 13 renal sarcomas of rats were incubated after excision under standardized conditions with 14C- and 3H-thymidine successively. Another ten tumors were evaluated after in vivo double injection of 14C and 3H-thymidine into s...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/BF00391832

    authors: Lang W,Kienzle S,Georgii A

    更新日期:1983-01-01 00:00:00

  • Phase II study of 5-fluoruracil leucovorin and azidothymidine in patients with metastatic colorectal cancer.

    abstract::The primary objective of this study was to determine the response rate of patients with metastatic colorectal cancer to combined therapy with 5-fluorouracil (5-FU), leucovorin, and intravenous azidothymidine (AZT), a thymidine nucleoside analog. By itself, AZT has limited antineoplastic efficacy. However, experimental...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF01213552

    authors: Clark J,Sikov W,Cummings F,Browne M,Akerley W,Wanebo H,Weitberg A,Kennedy T,Cole B,Bigley J,Beitz J,Darnowski J

    更新日期:1996-01-01 00:00:00

  • High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event.

    abstract:PURPOSE:(1) To test whether in genomewide expression profiling differentially expressed genes were also distinct on the protein level including KIT and PDGFRA (2) to correlate the expression with clinicopathological parameters (3) to identify activating mutations that might be eligible for tyrosine kinase inhibitor the...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-011-1107-9

    authors: Knösel T,Chen Y,Altendorf-Hofmann A,Danielczok C,Freesmeyer M,Settmacher U,Wurst C,Schulz S,Yang LL,Petersen I

    更新日期:2012-03-01 00:00:00

  • Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells.

    abstract:PURPOSE:To discover new molecular targets for cancer therapy and diagnosis, we surveyed signal transducers and activators of transcription 3 (Stat3)-regulated genes, because constitutive activation of Stat3 is associated with a wide variety of human malignancies. METHODS:We investigated the Stat3-regulated genes in 29...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-007-0318-6

    authors: Tomida M,Ohtake H,Yokota T,Kobayashi Y,Kurosumi M

    更新日期:2008-05-01 00:00:00

  • Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.

    abstract:BACKGROUND:Death-associated protein kinase (DAPK) and adenomatous polyposis coli gene (APC) have been recently shown to be associated with outcome in patients with esophageal carcinoma, especially adenocarcinoma. We wanted to validate the correlation of these two markers with outcome by detecting methylated DNA sequenc...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-009-0564-x

    authors: Hoffmann AC,Vallböhmer D,Prenzel K,Metzger R,Heitmann M,Neiss S,Ling F,Hölscher AH,Schneider PM,Brabender J

    更新日期:2009-09-01 00:00:00

  • Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer.

    abstract::To evaluate the epidermal growth factor receptor (EGFR) protein expression, gene mutations and amplification as predictors of clinical outcome in patients with non-small-cell lung cancer (NSCLC) receiving gefitinib, we have performed fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). We investig...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-007-0320-z

    authors: Sasaki H,Endo K,Okuda K,Kawano O,Kitahara N,Tanaka H,Matsumura A,Iuchi K,Takada M,Kawahara M,Kawaguchi T,Yukiue H,Yokoyama T,Yano M,Fujii Y

    更新日期:2008-05-01 00:00:00

  • Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy.

    abstract:PURPOSE:Two large, randomized, placebo-controlled trials (IRESSA NSCLC Trial Assessing Combination Therapy; INTACT 1 and 2) in non-small-cell lung cancer (NSCLC) failed to show survival benefit for gefitinib (IRESSA) in combination with first-line platinum-based chemotherapy. Epidermal growth factor receptor (EGFR) sta...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-008-0466-3

    authors: Giaccone G,Iacona RB,Fandi A,Janas M,Ochs JS,Herbst RS,Johnson DH

    更新日期:2009-03-01 00:00:00

  • Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis.

    abstract:PURPOSE:To determine the incidence of hepatocellular carcinoma in cirrhosis and to examine the influence of age and sex, and the contribution of etiological factors. METHODS:967 patients with liver cirrhosis and free of hepatocellular carcinoma were enrolled in this longitudinal, retrospective and observational study....

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s004320050215

    authors: del Olmo JA,Serra MA,Rodríguez F,Escudero A,Gilabert S,Rodrigo JM

    更新日期:1998-01-01 00:00:00

  • Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.

    abstract:PURPOSE:Despite great progress in the diagnosis and treatment of localized prostate cancer (PCa), there remains a need for new diagnostic markers that can accurately distinguish indolent and aggressive variants. One promising approach is the antibody-based targeting of prostate stem cell antigen (PSCA), which is freque...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-017-2472-9

    authors: Kessler C,Pardo A,Tur MK,Gattenlöhner S,Fischer R,Kolberg K,Barth S

    更新日期:2017-10-01 00:00:00

  • Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.

    abstract:PURPOSE:Putative tumor suppressor genes LATS1 and LATS2 are implicated in the regulation of the cell cycle at the G2/M and G1/S phase, respectively. This study investigated possible correlations of intra-tumoral LATS1 and LATS2 mRNA levels with response to epirubicin plus cyclophosphamide (EC) or docetaxel (DOC) treatm...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-007-0194-0

    authors: Takahashi Y,Miyoshi Y,Morimoto K,Taguchi T,Tamaki Y,Noguchi S

    更新日期:2007-08-01 00:00:00

  • Proliferation of tumor spheroids after shock-wave treatment.

    abstract::Multicellular tumor spheroids (MCTS) grown from the bladder cancer cell line RT112 and from the prostate cancer cell line PCA were exposed to 200 or 800 electromagnetically generated focused ultrasound shock waves. RT112 cells showed a distinct but transient decrease in proliferation whereas the effect of PCA cells wa...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/BF01240146

    authors: Nicolai H,Steinbach P,Knuechel-Clarke R,Grimm D,Roessler W,Wieland WF,Hofstaedter F

    更新日期:1994-01-01 00:00:00

  • Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer.

    abstract:BACKGROUND:Molecular metastases are precursors of postoperative recurrence, detected by molecular-biological tools. Chemokines and their receptors contribute to dissemination and local immune recognition. A strong expression of the chemokine receptor CCR5 is associated with non-metastatic colorectal cancer and increase...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-011-0980-6

    authors: Schimanski CC,Moehler M,Gockel I,Zimmermann T,Lang H,Galle PR,Berger MR

    更新日期:2011-07-01 00:00:00

  • Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.

    abstract:PURPOSE:The ENEST1st sub-analysis presents data based on Philadelphia chromosome (Ph) status, i.e., Ph+ and Ph-/BCR-ABL1 + chronic myeloid leukemia. METHODS:Patients received nilotinib 300 mg twice daily, up to 24 months. RESULTS:At screening, 983 patients were identified as Ph+ and 30 patients as Ph-/BCR-ABL + based...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00432-017-2359-9

    authors: Hochhaus A,Mahon FX,le Coutre P,Petrov L,Janssen JJWM,Cross NCP,Rea D,Castagnetti F,Hellmann A,Rosti G,Gattermann N,Coronel MLP,Gutierrez MAE,Garcia-Gutierrez V,Vincenzi B,Dezzani L,Giles FJ

    更新日期:2017-07-01 00:00:00

  • Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine.

    abstract::Indirubin, a 3, 2' bisindole isomer of indigo, has originally been identified as the active principle of a traditional Chinese preparation and has been proven to exhibit antileukemic effectiveness in chronic myelocytic leukemia. Indirubin was detected to represent a novel lead structure with potent inhibitory potentia...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s00432-004-0579-2

    authors: Eisenbrand G,Hippe F,Jakobs S,Muehlbeyer S

    更新日期:2004-11-01 00:00:00

  • Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.

    abstract:PURPOSE:We have demonstrated that overexpression of osteopontin (OPN) could contribute to metastasis in hepatocellular carcinoma (HCC), and that OPN-positive cancer cells are often localized in the periphery of cancer nodules adjacent to stromal cells. This study was to identify the difference of intratumor genomic abe...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-009-0695-0

    authors: Wu JC,Sun BS,Ren N,Ye QH,Qin LX

    更新日期:2010-04-01 00:00:00

  • GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.

    abstract:PURPOSE:The orphan, membrane-bound estrogen receptor (GPER) is expressed at high levels in a large fraction of breast cancer patients, and its expression is favorable for patients' survival. We investigated the role of GPER as a potential tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells. METHODS:The effect of...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-014-1598-2

    authors: Weißenborn C,Ignatov T,Poehlmann A,Wege AK,Costa SD,Zenclussen AC,Ignatov A

    更新日期:2014-04-01 00:00:00

  • Preoperative cervical lymph node size evaluation in patients with malignant head/neck tumors: comparison between ultrasound and computer tomography.

    abstract:PURPOSE:The spread of malignant lymph nodes due to malignancies of the head and neck is systematically observed. However, sentinel lymph nodes in the cervical region, such as in the axillary or supraclavicular regions, are not described. Therefore, precise preoperative lymph node screening of all neck compartments is r...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-008-0487-y

    authors: Hohlweg-Majert B,Metzger MC,Voss PJ,Hölzle F,Wolff KD,Schulze D

    更新日期:2009-06-01 00:00:00

  • Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.

    abstract::The antitumor and anti-metastatic effects of a potent angiogenesis inhibitor, O-(chloroacetyl-carbamoyl)fumagillol (TNP-470), was investigated in a highly metastatic model of human hepatocellular carcinoma-LCI-D20. Small pieces of LCI-D20 tumor tissue were implanted subcutaneously into the right axillary region of 24 ...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/BF01240121

    authors: Xia JL,Yang BH,Tang ZY,Sun FX,Xue Q,Gao DM

    更新日期:1997-01-01 00:00:00

  • [Permeability of N,N-bis(2-chloroethyl)-diamido-phosphoric-acid into tumor cells (author's transl)].

    abstract::The uptake of tritiated N,N-bis(2-chloroethyl)-diamido-phosphoric-acid into Ehrlich-Ascites-Tumor cells of mice was studied by means of the siliconoil-filtration technique. At 10 mM concentration no permeation of the metabolite into the tumor cells could be found within 5 min at 1 degrees C, while its congenors cyclop...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/BF00406573

    authors: Lenssen U,Hohorst HJ

    更新日期:1979-02-19 00:00:00

  • Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).

    abstract:PURPOSE:The aim of this study was to assess the impact of cyclin D1 overexpression (considered separately or jointly with previously assessed p53 and pRb statuses) on survival in a group of 111 surgically treated non-small cell lung cancer patients (NSCLC). METHODS:Cyclin D1 accumulation was assessed immunohistochemic...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-004-0661-9

    authors: Dworakowska D,Jassem E,Jassem J,Boltze C,Wiedorn KH,Dworakowski R,Skokowski J,Jaśkiewicz K,Czestochowska E

    更新日期:2005-07-01 00:00:00

  • hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.

    abstract:PURPOSE:Natural killer (NK) cells can kill transformed cells and represent anti-tumor activities for improving the immunotherapy of cancer. In previous works, we established human interleukin-15 (hIL-15) gene-modified NKL cells (NKL-IL15) and demonstrated their efficiency against human hepatocarcinoma cells (HCCs) in v...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-018-2654-0

    authors: Jiang W,Zhang C,Tian Z,Zhang J

    更新日期:2018-07-01 00:00:00

  • The clinical usefulness of optical coherence tomography during cancer interventions.

    abstract:INTRODUCTION:Tumor detection and visualization plays a key role in the clinical workflow of a patient with suspected cancer, both in the diagnosis and treatment. Several optical imaging techniques have been evaluated for guidance during oncological interventions. Optical coherence tomography (OCT) is a technique which ...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-018-2690-9

    authors: van Manen L,Dijkstra J,Boccara C,Benoit E,Vahrmeijer AL,Gora MJ,Mieog JSD

    更新日期:2018-10-01 00:00:00

  • A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.

    abstract::159 "poor risk" patients with previously untreated small cell lung cancer were entered into a randomised study of intravenous bolus versus continuous infusion chemotherapy with doxorubicin on weeks 1, 3, 5 and ifosfamide with mesna on weeks 2, 4, 6. Oral etoposide was given on days 1-5, 15-19, and 29-33. There was no ...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF01613219

    authors: Anderson H,Prendiville J,Thatcher N,Radford JA,Swindell R

    更新日期:1991-01-01 00:00:00

  • Therapeutic outcome and prognostic factors in sinonasal rhabdomyosarcoma: a single-institution case series.

    abstract:BACKGROUND:The purpose of this study was to explore the demographics, multimodality therapeutic outcomes*** and prognostic factors in sinonasal rhabdomyosarcoma (SNRMS). METHODS:We conducted a retrospective analysis of 40 patients who underwent treatment of SNRMS from March 2007 to March 2018. The Kaplan-Meier method ...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00432-019-03009-8

    authors: Li W,Lu H,Wang D

    更新日期:2019-11-01 00:00:00

  • Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems.

    abstract::Intravenous tumor cell injection and spontaneously metastasising transplantable tumors have been used as models for haematogenous tumor spread. To evaluate the validity of these two experimental approaches for the study of blood coagulability and metastases, the effect of anticoagulants on "secondary" tumor growth was...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/BF00410113

    authors: Maat B,Hilgard P

    更新日期:1981-01-01 00:00:00

  • Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?

    abstract:INTRODUCTION:Evidence shows that exon 19 deletions (19del) and exon 21 Leu858Arg point mutation (L858R) of EGFR are different in response to EGFR tyrosine kinase inhibitor (EGFR-TKI) therapy in advanced lung cancers. However, the impact of the two mutational types in the early stage lung adenocarcinoma is unknown. MET...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-017-2526-z

    authors: Zhang Y,Ma Y,Li Y,Shen X,Yu Y,Pan Y,Zhang Y,Yu S,Zheng D,Zhao Y,Hu H,Sun Y,Zhang Y,Xiang J,Chen H

    更新日期:2018-01-01 00:00:00

  • Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.

    abstract:PURPOSE:Recently, we identified the microRNA-99 family as unfavorable prognostic factor in patients with pancreatic ductal adenocarcinoma (PDAC). The aim of this study is to evaluate its value as circulating biomarker for PDAC. METHODS:Tissue and corresponding preoperative blood samples of 181 patients with PDAC UICC ...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-018-2749-7

    authors: Stroese AJ,Ullerich H,Koehler G,Raetzel V,Senninger N,Dhayat SA

    更新日期:2018-12-01 00:00:00

  • Estrogen receptor beta is expressed in human stomach adenocarcinoma.

    abstract:PURPOSE:In stomach adenocarcinoma, the role of the hormonal receptor, estrogen receptor (ER), has been controversial. Recently, a new estrogen receptor, called estrogen receptor beta (ER beta), was found to be expressed in various tissues including normal gastrointestinal tract. In this paper, the expression of ER beta...

    journal_title:Journal of cancer research and clinical oncology

    pub_type: 杂志文章

    doi:10.1007/s00432-002-0336-3

    authors: Matsuyama S,Ohkura Y,Eguchi H,Kobayashi Y,Akagi K,Uchida K,Nakachi K,Gustafsson JA,Hayashi S

    更新日期:2002-06-01 00:00:00